Analyst Observations
Published: September 11, 2026
This content is for informational purposes only. This should not be construed as solicitation. The general public should consult their financial advisor for additional information related to investment decisions.
Comments include: MRK, SPHR, & UNH.

 

MRK Merck & Co., Inc. ($144.52) - Drugs - Shares of MRK broke a double bottom at $144, ending its streak of three consecutive buy signals. That said, the 5 for 5'er continues to trades in a positive trend and exhibit relative strength, keeping it firmly in buy territory. From here, initial support lies at $128 then $122, while previous resistance at $134 could serve as support as well.
SPHR Sphere Entertainment Co. ($142.49) - Leisure - SPHR reversed into Xs and broke a double top at $146 to return to a buy signal after testing support in the mid $130s. Action at the end of August saw the stock reverse down into Os on its market RS chart, dropping SPHR down to a 4 for 5'er in TA rating. From here, note the August chart highs at $180, while support beyond the mid $130s resides in the mid $120 to $130 range.
UNH UnitedHealth Group Incorporated ($376.65) - Healthcare - Shares of UNH fell on Friday, completing a second consecutive sell signal with a double bottom break at $376. That said, the 4 for 5'er has rebounded sharply off its lows over the last several month, with it still trading in a positive trend. Investors could buy here with it trading in actionable territory, but should monitor for further deterioration.
Back to report

DISCLOSURE

This report is for Internal Use Only and not for distribution to the public. While we make every effort to be free of errors in this report, it contains data obtained from other sources. We believe these sources to be reliable, but we cannot guarantee their accuracy. Investors who use options should read the Options Disclosure Document before making any particular investment decision. Officers or employees of this firm may now or in the future have a position in the stocks mentioned in this report. Dorsey, Wright is a Registered Investment Advisor with the U.S. Securities & Exchange Commission. Copies of Form ADV Part II are available upon request.
Equity prices provided by Thomson-Reuters. Cross Rate prices provided by Tenfore Systems. Option prices provided by OPRA
Copyright © 1995-2026 Dorsey, Wright & Associates, LLC.®
All quotes displayed are delayed 20 minutes
Disclaimer/Terms of Use/Copyright